Novartis AG (Swiss: NOVN)

Lichtstrasse 35
CH-4056 Basel, Switzerland (Map)
Phone: +41-61-324-1111
Fax: +41-61-324-8001
Primary US Office:
Subscribers Only
http://www.novartis.com

Hoover's coverage by Anne Law

Overview

Although it's based in neutral Switzerland, Novartis has been aggressive in attacking illnesses on multiple fronts, including pharmaceuticals, vaccines, and consumer health. Its largest division, Pharmaceuticals, develops and manufactures prescription drugs for blood pressure, cancer, and other ailments. Novartis' Sandoz subsidiary produces generic drugs and active pharmaceutical ingredients, while the Vaccine and Diagnostics segment makes immune health and blood-screening tools. Its Alcon division makes ophthalmic drugs, surgery systems, and contact lenses. The Consumer Health unit includes OTC medications such as Excedrin and Theraflu, as well as Animal Health's agricultural animal and pet care products.

Sample Overview & History

Key Numbers from Hoover's UK

Key financials for Novartis AG (Swiss: NOVN)

Company Type Public (Swiss: NOVN; NYSE: NVS [ADR])
Fiscal Year-End December
2010 Sales (mil.) £33,329.0
1-Year Sales Growth 14.3%
2010 Net Income (mil.) £6,330.8
1-Year Net Income Growth 16.6%
2010 Employees 119,418
1-Year Employee Growth 19.6%
Get more Key Numbers
TIP: Understand how a company performs against its industry by reviewing Comparison Data. Column-to-column comparisons to the industry and the market are available with a Hoover's subscription.
TIP: Subscribers have access to detailed financial data (income statement, balance sheet, cash flow) for more than 500,000 public and private companies in the UK.

Key People from Hoover's UK

Key people and executives for Novartis AG (Swiss: NOVN)

Chairman Daniel L. Vasella
(Subscribers see complete biographies -- view sample)
CEO Joseph (Joe) Jimenez Jr.
CFO Jonathan R. (Jon) Symonds
TIP: Use Build Executive List to target decision makers by industry, geography, sales, net income, and number of employees.

Top Competitors from Hoover's UK

Top competitors of Novartis AG (Swiss: NOVN)

There are 23 competitors for Novartis; see more.
TIP: Analyze the Competitive Landscape to view a head-to-head comparison of a firm's profitability, operations, growth, and valuation versus that of its top three competitors.

Industry Information from Hoover's UK

First Research Industry Profiles Extensive Industry Intelligence

Hoover's Industries

More Industry Information
TIP: Hoover's proprietary industry structure allows you to tell at-a-glance how diversified a company's operations are, and which line of business can be considered a company's primary industry.

Subsidiaries/Affiliates Covered By Hoover's UK

Subsidiaries/affiliates of Novartis AG (Swiss: NOVN)

View more Subsidiaries/Affiliates of Novartis
TIP: Use subsidiary and affiliate information to determine easy cross-sell and upsell opportunities within an organization or business line. Hoover's subscribers have full access to detailed Family Tree information.

Rankings from Hoover's UK

See how Novartis AG (Swiss: NOVN) ranks in standard industry listings such as Fortune 500, S&P 500, and Dow Jones

  • Dow Jones Global Titans
  • #32 in FT Global 500 (June 2011)
  • STOXX Europe 50
  • Swiss Market
TIP: Hoover's subscribers have access to FT 500 and other rankings that make targeted list building easy.

Subscribers Get More!

Search Hoover's UK

View Hoover's UK Free Content

Buy A Report on Novartis:

Sample UK Subscriber Content


Bizmology

No Christmas wrapping on toy safety reforms

by Linnea Kirgan, Jan. 2nd, 2008
Read more at Bizmology.com.


Companies That Exceed Expectations

Who's going above and beyond the status quo? Learn more about these groundbreaking companies!

Current Edition: Click Here



Small Business Expert

Presented by Comcast Business Class

Read More from the Current Edition: Performance Reviews

Click Here


Copyright © 2012, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy